ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1045
-0,50%
Bitcoin
66.886,39
2,52%
Brent Oil
83,76
0,67%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Zura Bio Ltd (ZURA)

  7. Zura Bio Ltd (ZURA) Notícias

ZURA

Zura Bio (ZURA)

Zura Bio Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ZURA
DataHoraFonteTítuloCódigoCompanhia
09/05/202407:00Business WireZura Bio Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
18/04/202410:22Business WireZura Bio Announces Oversubscribed $112.5 Million Private PlacementNASDAQ:ZURAZura Bio Ltd
08/04/202407:00Business WireZura Bio Announces Robert Lisicki as CEO and DirectorNASDAQ:ZURAZura Bio Ltd
28/03/202407:00Business WireZura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive OfficerNASDAQ:ZURAZura Bio Ltd
04/03/202408:00Business WireZura Bio Announces Participation at March ConferencesNASDAQ:ZURAZura Bio Ltd
23/02/202418:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
14/02/202411:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZURAZura Bio Ltd
02/02/202408:00Business WireZura Bio Announces Participation at February Investor ConferencesNASDAQ:ZURAZura Bio Ltd
26/01/202413:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
08/01/202408:00Business WireZura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMONASDAQ:ZURAZura Bio Ltd
03/01/202408:00Business WireZura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology SummitNASDAQ:ZURAZura Bio Ltd
04/12/202308:00Business WireZura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in BangkokNASDAQ:ZURAZura Bio Ltd
17/11/202319:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
14/11/202308:00Business WireZura Bio Appoints Arnout Ploos van Amstel to its Board of DirectorsNASDAQ:ZURAZura Bio Ltd
13/11/202308:30Business WireZura Bio Reports Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
15/09/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZURAZura Bio Ltd
14/09/202318:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ZURAZura Bio Ltd
12/09/202306:00Business WireZura Bio Enters into Sponsored Research Agreement with Benaroya Research InstituteNASDAQ:ZURAZura Bio Ltd
24/08/202322:54Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZURAZura Bio Ltd
14/08/202308:00Business WireZura Bio Reports Second Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
23/06/202309:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZURAZura Bio Ltd
23/06/202307:30Business WireZura Bio to Join the Russell 2000® and Russell 3000® IndexesNASDAQ:ZURAZura Bio Ltd
22/06/202318:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZURAZura Bio Ltd
22/06/202318:20Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ZURAZura Bio Ltd
22/06/202318:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZURAZura Bio Ltd
16/06/202314:31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ZURAZura Bio Ltd
14/06/202307:03Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ZURAZura Bio Ltd
06/06/202305:00Business WireZura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17 and Anti-BAFF Dual AntagonistNASDAQ:ZURAZura Bio Ltd
19/05/202317:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ZURAZura Bio Ltd
12/05/202318:27Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ZURAZura Bio Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:ZURA

Seu Histórico Recente

BIBX
USTUSDT
Terra Luna Classic
BOV
GDBR34M
Gen Dynamics DRN
BIT
F15712
Vontobel Financial Produ...
NASDAQ
BLUE
bluebird bio
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados